Silverarc Capital Management, LLC Madrigal Pharmaceuticals, Inc. Transaction History

Silverarc Capital Management, LLC

  • $416 Million
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$231.06 - $307.08 $9.22 Million - $12.3 Million
-39,898 Reduced 79.96%
10,000 $2.42 Million
Q4 2022

Feb 14, 2023
BUY
$58.39 - $296.54 $2.91 Million - $14.8 Million
49,898 New
49,898 $14.5 Million
Q3 2021

Nov 15, 2021
SELL
$78.35 - $105.02 $194,308 - $260,449
-2,480 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$97.2 - $137.59 $241,056 - $341,223
2,480 New
2,480 $242,000

Others Institutions Holding MDGL

# of Institutions
335
Shares Held
22.3M
Call Options Held
960K
Put Options Held
940K
View Full List

About MADRIGAL PHARMACEUTICALS, INC.

MDGL Quotes by TradingView
  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.75B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Silverarc Capital Management, LLC Portfolio

Follow Silverarc Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverarc Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email